195 related articles for article (PubMed ID: 15353483)
1. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
[TBL] [Abstract][Full Text] [Related]
2. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
[TBL] [Abstract][Full Text] [Related]
3. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice.
Tomoda K; Yoneda-Kato N; Fukumoto A; Yamanaka S; Kato JY
J Biol Chem; 2004 Oct; 279(41):43013-8. PubMed ID: 15299027
[TBL] [Abstract][Full Text] [Related]
4. Bcr-Abl oncogene stimulates Jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells.
Yang KT; Wang MC; Chen JY; Hsu MC; Hung WC
J Cell Physiol; 2011 Nov; 226(11):2849-56. PubMed ID: 21935931
[TBL] [Abstract][Full Text] [Related]
5. JAB1/CSN5 and the COP9 signalosome. A complex situation.
Chamovitz DA; Segal D
EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
[TBL] [Abstract][Full Text] [Related]
6. Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines.
Jonuleit T; van der Kuip H; Miething C; Michels H; Hallek M; Duyster J; Aulitzky WE
Blood; 2000 Sep; 96(5):1933-9. PubMed ID: 10961897
[TBL] [Abstract][Full Text] [Related]
7. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
[TBL] [Abstract][Full Text] [Related]
8. A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells.
Komatsu N; Watanabe T; Uchida M; Mori M; Kirito K; Kikuchi S; Liu Q; Tauchi T; Miyazawa K; Endo H; Nagai T; Ozawa K
J Biol Chem; 2003 Feb; 278(8):6411-9. PubMed ID: 12456669
[TBL] [Abstract][Full Text] [Related]
9. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
10. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
[TBL] [Abstract][Full Text] [Related]
11. Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1.
Chopra S; Fernandez De Mattos S; Lam EW; Mann DJ
J Biol Chem; 2002 Sep; 277(36):32413-6. PubMed ID: 12119282
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
13. The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase progression via deneddylation of SCF Cul1.
Yang X; Menon S; Lykke-Andersen K; Tsuge T; Di Xiao ; Wang X; Rodriguez-Suarez RJ; Zhang H; Wei N
Curr Biol; 2002 Apr; 12(8):667-72. PubMed ID: 11967155
[TBL] [Abstract][Full Text] [Related]
14. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation.
Kim BC; Lee HJ; Park SH; Lee SR; Karpova TS; McNally JG; Felici A; Lee DK; Kim SJ
Mol Cell Biol; 2004 Mar; 24(6):2251-62. PubMed ID: 14993265
[TBL] [Abstract][Full Text] [Related]
15. Gfer inhibits Jab1-mediated degradation of p27kip1 to restrict proliferation of hematopoietic stem cells.
Teng EC; Todd LR; Ribar TJ; Lento W; Dimascio L; Means AR; Sankar U
Mol Biol Cell; 2011 Apr; 22(8):1312-20. PubMed ID: 21346186
[TBL] [Abstract][Full Text] [Related]
16. BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.
Parada Y; Banerji L; Glassford J; Lea NC; Collado M; Rivas C; Lewis JL; Gordon MY; Thomas NS; Lam EW
J Biol Chem; 2001 Jun; 276(26):23572-80. PubMed ID: 11323429
[TBL] [Abstract][Full Text] [Related]
17. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
[TBL] [Abstract][Full Text] [Related]
18. Small Jab1-containing subcomplex is regulated in an anchorage- and cell cycle-dependent manner, which is abrogated by ras transformation.
Fukumoto A; Tomoda K; Kubota M; Kato JY; Yoneda-Kato N
FEBS Lett; 2005 Feb; 579(5):1047-54. PubMed ID: 15710389
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma.
Tsuchida R; Miyauchi J; Shen L; Takagi M; Tsunematsu Y; Saeki M; Honna T; Yamada S; Teraoka H; Kato JY; Mizutani S
Jpn J Cancer Res; 2002 Sep; 93(9):1000-6. PubMed ID: 12359053
[TBL] [Abstract][Full Text] [Related]
20. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
